Ginkgo Bioworks Holdings Inc (NYSE:DNA)
| 1.99 Delayed Data As of Feb 07 |  +0.03 / +1.53%Today’s Change | 1.45 Today|||52-Week Range 6.31 | +17.75% Year-to-Date |
Latest DNA News | Press Releases
| 3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street Feb 07 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.96 |
| Today’s open | 1.92 |
| Day’s range | 1.90 - 2.02 |
| Volume | 19,680,340 |
| Average volume (3 months) | 23,757,436 |
| Market cap | $3.2B |
Data as of 3:59pm ET, 02/07/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +11.19% |
| Earnings growth (next 5 years) | +37.73% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 42.67 |
| Price/Book | 2.21 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 27, 2023 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $313.8M |
| Annual profit (last year) | -$1.8B |
| Net profit margin | -583.12% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters --, -- |
Forecasts
